Acotec Scientific Holdings Limited (HKG:6669)
Hong Kong
· Delayed Price · Currency is HKD 9.80
-0.69 (-6.58%)
Apr 29, 2026, 4:08 PM HKT
HKG:6669 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 644.63 | 533.99 | 473.85 | 395.55 | 303.81 | Upgrade
|
| Revenue Growth (YoY) | 20.72% | 12.69% | 19.80% | 30.19% | 56.63% | Upgrade
|
| Cost of Revenue | 168.32 | 131.27 | 96.43 | 59.19 | 37.87 | Upgrade
|
| Gross Profit | 476.31 | 402.72 | 377.42 | 336.35 | 265.94 | Upgrade
|
| Selling, General & Admin | 182.33 | 157.71 | 181.32 | 160.51 | 116.89 | Upgrade
|
| Research & Development | 213.67 | 216.77 | 190.07 | 183.8 | 141.29 | Upgrade
|
| Other Operating Expenses | -24.45 | -9.35 | -16.92 | -7.1 | - | Upgrade
|
| Operating Expenses | 371.55 | 365.02 | 354.29 | 337.31 | 257.37 | Upgrade
|
| Operating Income | 104.76 | 37.71 | 23.13 | -0.96 | 8.57 | Upgrade
|
| Interest Expense | -9.39 | -9.9 | -9.83 | -1.42 | -3.82 | Upgrade
|
| Interest & Investment Income | 25.67 | 30.15 | 18.51 | 20.26 | 4.73 | Upgrade
|
| Earnings From Equity Investments | -0.7 | 0.1 | -0.6 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -12.21 | -0.16 | -13.7 | 52.97 | -8.79 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.89 | -1.61 | -0.13 | -0.34 | 6.69 | Upgrade
|
| EBT Excluding Unusual Items | 107.25 | 56.29 | 17.37 | 70.52 | 7.38 | Upgrade
|
| Gain (Loss) on Sale of Investments | 15.83 | 2.92 | -2.77 | -0.19 | -33.4 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.9 | -6.61 | -0.15 | -0.01 | -0.1 | Upgrade
|
| Other Unusual Items | - | - | - | - | -41.13 | Upgrade
|
| Pretax Income | 122.18 | 52.6 | 14.45 | 70.32 | -67.24 | Upgrade
|
| Income Tax Expense | 3 | 0.32 | -0.04 | 0.18 | 11.83 | Upgrade
|
| Earnings From Continuing Operations | 119.18 | 52.28 | 14.49 | 70.14 | -79.08 | Upgrade
|
| Net Income | 119.18 | 52.28 | 14.49 | 70.14 | -79.08 | Upgrade
|
| Net Income to Common | 119.18 | 52.28 | 14.49 | 70.14 | -79.08 | Upgrade
|
| Net Income Growth | 127.97% | 260.88% | -79.35% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 302 | 301 | 301 | 300 | 248 | Upgrade
|
| Shares Outstanding (Diluted) | 302 | 301 | 301 | 300 | 248 | Upgrade
|
| Shares Change (YoY) | 0.20% | - | 0.49% | 20.78% | 33.16% | Upgrade
|
| EPS (Basic) | 0.40 | 0.17 | 0.05 | 0.23 | -0.32 | Upgrade
|
| EPS (Diluted) | 0.40 | 0.17 | 0.05 | 0.23 | -0.32 | Upgrade
|
| EPS Growth | 132.39% | 253.30% | -79.08% | - | - | Upgrade
|
| Free Cash Flow | - | 50.73 | -92.48 | -112.17 | -30.84 | Upgrade
|
| Free Cash Flow Per Share | - | 0.17 | -0.31 | -0.37 | -0.12 | Upgrade
|
| Gross Margin | 73.89% | 75.42% | 79.65% | 85.04% | 87.53% | Upgrade
|
| Operating Margin | 16.25% | 7.06% | 4.88% | -0.24% | 2.82% | Upgrade
|
| Profit Margin | 18.49% | 9.79% | 3.06% | 17.73% | -26.03% | Upgrade
|
| Free Cash Flow Margin | - | 9.50% | -19.52% | -28.36% | -10.15% | Upgrade
|
| EBITDA | 124.18 | 57.12 | 38.43 | 8.65 | 14.21 | Upgrade
|
| EBITDA Margin | 19.26% | 10.70% | 8.11% | 2.19% | 4.68% | Upgrade
|
| D&A For EBITDA | 19.42 | 19.42 | 15.3 | 9.6 | 5.64 | Upgrade
|
| EBIT | 104.76 | 37.71 | 23.13 | -0.96 | 8.57 | Upgrade
|
| EBIT Margin | 16.25% | 7.06% | 4.88% | -0.24% | 2.82% | Upgrade
|
| Effective Tax Rate | 2.45% | 0.61% | - | 0.25% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.